Safety Reference
Danger
H350May cause cancer
H341Suspected of causing genetic defects
H361Suspected of damaging fertility or the unborn child
H371May cause damage to organs
H372
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 29767-20-2
Etoposide
antineoplastic chemotherapeutic agent
Teniposide is an antineoplastic active pharmaceutical ingredient used in the manufacturing of pharmaceutical products. It is reported to cause developmental toxicity according to government labeling requirements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Teniposide (CAS 29767-20-2) is 2938.90.
2938.90
2938 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
NRUKOCRGYNPUPR-QBPJDGROSA-N
COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O